RANK Ligand

RANK Ligand

Name

Description

Product #

Price

Quantity

Shipping Method

  • View Data Sheet

    Description:

    RANK Ligand Soluble Mouse Recombinant

    Soluble Receptor Activator of NFkB Ligand, TNFSF11, TRANCE, TNF-related activation-induced cytokine, OPGL, ODF, Osteoclast differentiation factor, Tumor necrosis factor ligand superfamily member 11, Receptor activator of nuclear factor kappa B ligand, RANKL, Osteoprotegerin ligand, CD254 antigen, sRANKL, sOdf.

    Product # :

    CYT-320

    Price :

    Quantity :

    Shipping Method :

    Room Temp Icon

    Shipped at Room temp

    Add To Cart

    More Info

    • purity
    • More Info

    Purity

    Greater than 95.0% as determined by SDS-PAGE.

    More Info

    • Introduction
    • Synonyms
    • Physical Appearance
    • Stability
    • Solubility
    • Amino Acid Sequence
    Rankl Mouse
  • View Data Sheet

    Description:

    RANK Human Recombinant, Sf9

    TNFRSF11A, ODFR, RANK, Tumor Necrosis Factor Receptor Superfamily, Member 11a, Activator Of NFKB, Receptor Activator Of Nuclear Factor-Kappa B, CD265 Antigen, LOH18CR1, TRANCER, CD265

    Product # :

    CYT-932

    Price :

    Quantity :

    Shipping Method :

    Ice Icon

    Shipped with Ice Packs

    Add To Cart

    More Info

    • purity
    • More Info

    Purity

    Greater than 90.0% as determined by SDS-PAGE.

    More Info

    • Introduction
    • Synonyms
    • Physical Appearance
    • Stability
    • Amino Acid Sequence
    Rank Human
  • View Data Sheet

    Description:

    RANK Human Recombinant

    TNFRSF11A, ODFR, RANK, Tumor Necrosis Factor Receptor Superfamily, Member 11a, Activator Of NFKB, Receptor Activator Of Nuclear Factor-Kappa B, CD265 Antigen, LOH18CR1, TRANCER, CD265

    Product # :

    CYT-734

    Price :

    Quantity :

    Shipping Method :

    Room Temp Icon

    Shipped at Room temp

    Add To Cart

    More Info

    • purity
    • More Info

    Purity

    Greater than 98.0% as determined by:
    (a) Analysis by RP-HPLC.
    (b) Analysis by SDS-PAGE.

    More Info

    • Introduction
    • Synonyms
    • Physical Appearance
    • Stability
    • Solubility
    • Amino Acid Sequence
    Tnfrsf11A Human
  • View Data Sheet

    Description:

    Soluble RANK Ligand Human Recombinant, His Tag

    Soluble Receptor Activator of NFkB Ligand, TNFSF11, TRANCE, TNF-related activation-induced cytokine, OPGL, ODF, Osteoclast differentiation factor, Tumor necrosis factor ligand superfamily member 11, Receptor activator of nuclear factor kappa B ligand, RANKL, Osteoprotegerin ligand, CD254 antigen, sRANKL, sOdf, hRANKL2.

    Product # :

    CYT-692

    Price :

    Quantity :

    Shipping Method :

    Ice Icon

    Shipped with Ice Packs

    Add To Cart

    More Info

    • purity
    • More Info

    Purity

    Greater than 80.0% as determined by SDS-PAGE.

    More Info

    • Introduction
    • Synonyms
    • Physical Appearance
    • Stability
    • Amino Acid Sequence
    Srankl Human His
  • View Data Sheet

    Description:

    Soluble RANK Ligand Human Recombinant, GST tag

    Soluble Receptor Activator of NFkB Ligand, TNFSF11, TRANCE, TNF-related activation-induced cytokine, OPGL, ODF, Osteoclast differentiation factor, Tumor necrosis factor ligand superfamily member 11, Receptor activator of nuclear factor kappa B ligand, RANKL, Osteoprotegerin ligand, CD254 antigen, sRANKL, sOdf, hRANKL2.

    Product # :

    CYT-631

    Price :

    Quantity :

    Shipping Method :

    Ice Icon

    Shipped with Ice Packs

    Add To Cart

    More Info

    • purity
    • More Info

    Purity

    Greater than 95.0% as determined by SDS-PAGE.

    More Info

    • Introduction
    • Synonyms
    • Physical Appearance
    • Stability
    Rankl Human Gst
  • View Data Sheet

    Description:

    RANK Ligand Soluble Human Recombinant

    Soluble Receptor Activator of NFkB Ligand, TNFSF11, TRANCE, TNF-related activation-induced cytokine, OPGL, ODF, Osteoclast differentiation factor, Tumor necrosis factor ligand superfamily member 11, Receptor activator of nuclear factor kappa B ligand, RANKL, Osteoprotegerin ligand, CD254 antigen, sRANKL, sOdf, hRANKL2.

    Product # :

    CYT-334

    Price :

    Quantity :

    Shipping Method :

    Room Temp Icon

    Shipped at Room temp

    Add To Cart

    More Info

    • purity
    • More Info

    Purity

    Greater than 95.0% as determined by analysis by SDS-PAGE.

    More Info

    • Introduction
    • Synonyms
    • Physical Appearance
    • Stability
    • Solubility
    • Amino Acid Sequence
    Rankl Human
  • View Data Sheet

    Description:

    Soluble RANK Ligand (158-316 a.a) Mouse Recombinant

    Soluble Receptor Activator of NFkB Ligand, TNFSF11, TRANCE, TNF-related activation-induced cytokine, OPGL, ODF, Osteoclast differentiation factor, Tumor necrosis factor ligand superfamily member 11, Receptor activator of nuclear factor kappa B ligand, RANKL, Osteoprotegerin ligand, CD254 antigen, sRANKL, sOdf.

    Product # :

    CYT-958

    Price :

    Quantity :

    Shipping Method :

    Ice Icon

    Shipped with Ice Packs

    Add To Cart

    More Info

    • purity
    • More Info

    Purity

    Greater than 90% as determined by SDS-PAGE.

    More Info

    • Introduction
    • Synonyms
    • Physical Appearance
    • Stability
    • Amino Acid Sequence
    Srankl 158 316 Mouse

About RANK Ligand:

RANKL aka RANK Ligand is receptor activator of nuclear factor kappa-Β ligand and also known as tumour necrosis factor ligand superfamily member 11 (TNFSF11), osteoclast differentiation factor (ODF), TNF-related activation-induced cytokine (TRANCE) and osteoprotegerin ligand (OPGL). It is a protein that is encoded by the TNFSF11 gene in humans.
RANKL is known as a type II membrane protein. It is a member of the tumour necrosis factor (TNF) superfamily. RANKL has been identified to control bone regeneration and modelling and also the immune system. RANKL is a binding partner of osteoprotegerin (OPG), a ligand for the receptor RANK, an apoptosis regulator gene and controls cell proliferation by modifying protein levels of ld4, ld2 and cyclin D1. RANKL is expressed in several organs and tissues such as skeletal muscle, liver, colon, adrenal gland, small intestine, thymus, osteoblast, mammary gland epithelial cells, pancreas and prostate. Variations in concentration levels of RANKL across several organs confirms the importance of RANKL in tissue growth and immune functions.

Function
RANKL is a part of the tumour necrosis factor (TNF) cytokine family. It binds to RANK on cells of the myeloid lineage and functions as a key factor for osteoclast differentiation and activation. RANKL can also bind to osteoprotegerin, a protein secreted mainly by cells of the osteoblast lineage and it is a potent inhibitor of osteoclast formation by preventing the binding of RANKL to RANK. RANKL also has functions in the immune system where it is expressed by T helper cells. It is thought to be involved in dendritic cell maturation. The protein is shown to be a dendritic cell survival factor and is involved in the regulation of T cell-dependent immune response. T cell activation was reported to induce expression of the gene and lead to an increase of osteoclastogenesis and bone loss. It was also shown to activate antiapoptotic kinase AKT/PKB through a signalling complex that involved SRC kinase and tumour necrosis factor receptor-associated factor 6 (TRAF6). This indicates that the protein may also have a role in the regulation of cell apoptosis.

Role in Cancer
Primary tumours commonly metastasize into the bone. Breast and prostate cancers have a greater chance of inducing secondary cancers within the bone. Stephen Paget’s seed and soil theory suggests that the microenvironment in bone creates a “soil2 for secondary tumours to grow in. Other studies suggest that the expression of RANKL allows sufficient micro environmental conditions to influence cancer cell migration (such as chronic lymphocytic leukaemia (CLL) and multiple myeloma). In patients with multiple myeloma, RANKL activity is greatly increased. RANKL surface expression and secreted RANKL expression was reported to be increased by 80% and 50% respectively. Therefore, RANKL is considered to be a key signal regulator for bone loss induced by cancer.